Risedronate prevents new vertebral fractures in postmenopausal women at high risk.

@article{Watts2003RisedronatePN,
  title={Risedronate prevents new vertebral fractures in postmenopausal women at high risk.},
  author={Nelson B. Watts and Robert G. Josse and Ronald C. Hamdy and Rodney A. Hughes and Michael D. Manhart and Ian Barton and D Calligeros and Dieter Felsenberg},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2003},
  volume={88 2},
  pages={
          542-9
        }
}
Independent risk factors for fracture include advanced age, preexisting fractures, and low bone mineral density. Rised-ronate has been shown in several large trials to be safe and effective for patients with osteoporosis, but its effects in populations at high risk are not well characterized. To determine the effect of risedronate on vertebral fracture in high-risk subjects, we pooled data from two randomized, double-blind studies [Vertebral Efficacy with Risedronate Therapy (VERT… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 53 CITATIONS, ESTIMATED 59% COVERAGE

FILTER CITATIONS BY YEAR

2003
2019

CITATION STATISTICS

  • 2 Highly Influenced Citations